FORTIS902.00

Fortis Healthcare Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersAPOLLOHOSPMAXHEALTHMEDANTAAUROPHARMALUPINALKEMLAURUSLABSMANKINDMcap ₹68,097 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations6,892.97,782.89,127.89,506.2
Other Income38.366.950.749.7
Total Income6,931.27,849.79,178.59,555.9
Expenses
+ Purchases of Stock-in-Trade1,603.31,838.12,108.72,176.4
+ Changes in Inventories15.4-7.9-20.0-28.9
+ Employee Benefit Expense1,119.51,167.21,296.61,388.3
+ Finance Costs131.0184.4314.5325.3
+ Depreciation & Amortisation342.5385.6449.4469.8
+ Other Expenses2,887.13,197.43,657.63,838.9
Total Expenses6,098.76,764.87,806.88,169.9
EBITDA1,267.61,587.92,085.02,131.4
EBIT925.11,202.31,635.61,661.6
Profit
PBT before Exceptional Items832.41,084.91,371.71,386.0
+ Exceptional Items16.0-89.3-22.2-25.3
Pretax Income848.5995.51,349.51,360.7
+ Current Tax190.0182.2208.5254.7
+ Deferred Tax22.815.493.253.5
Tax Expense212.8197.7301.7308.3
+ Share of Associates & JVs9.511.516.417.8
Net Income645.2809.41,064.21,070.2
+ Net Income — Continuing Ops635.7797.91,047.81,052.4
+ Other Comprehensive Income1.8-3.512.613.2
Total Comprehensive Income647.0805.91,076.81,083.4
Net Income to Common598.9774.21,041.81,047.9
Minority Interest46.335.222.422.3
Per Share
Basic EPS7.9310.2613.8013.88
Diluted EPS7.9310.2613.8013.88
Other Comprehensive Income — detail
+ Other Comprehensive Income-3.512.613.2
+ Items NOT to be Reclassified to P&L-2.2-8.0-1.01.7
+ Tax on Items NOT to be Reclassified-2.0-0.20.4
+ Tax on Items NOT to be Reclassified — alt tag-0.5
+ Items to be Reclassified to P&L3.42.513.3
+ Tax on Items to be Reclassified0.00.0-3.4
Comprehensive Income — Owners of Parent2.2-3.21,054.51,061.2
Comprehensive Income — Non-controlling Interests-0.5-0.322.322.2
Per Share — as-filed variants
Basic EPS — Continuing Operations7.9310.2613.8013.88
Diluted EPS — Continuing Operations7.9310.2613.8013.88
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit5,274.25,952.67,039.27,358.7
Gross Margin %76.5276.4877.1277.41
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)832.41,084.91,371.71,386.0
− Exceptional Items (reconciliation)16.0-89.3-22.2-25.3
Net Income Adj (tax-effected)633.2881.01,081.51,089.8
EPS Adj7.7811.1714.0214.13
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Filed Debt Equity0.000.000.00
Filed Dscr0.040.020.01
Filed Iscr0.090.070.07
Paid Up Equity Capital755.0755.0755.0755.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.